FDA Inspection
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. – FDA Inspection, Mar 14, 2025
Record Details
This FDA Inspection record concerns Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 14, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 1c51015f-b309-4ab7-b57b-45d6d3f3be3e
Inspection Facts
- Inspection number
- 1266335
- FDA center
- Human Drugs
Other FDA inspections of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2019 | Not classified | Office of Inspections and Investigations | |
| March 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 21, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
- FDA Inspection 1082456 - 2019-02-22
- FDA Inspection 1050487 - 2018-03-23
- FDA Inspection 934692 - 2015-05-15
- FDA Inspection 812363 - 2012-12-21
- FDA Inspection 709563 - 2010-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.